Division of Infectious Diseases and Immunology Research

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.
Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.
We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.
Core Faculty Investigators
Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies
Ramin Herati, MD
Assistant Professor, Department of Medicine
Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine
Bo Shopsin, MD, PhD
Associate Director, Research, Division of Infectious Diseases
Director, Molecular Epidemiology Director, Antimicrobial-Resistant Pathogens
Program Associate Director of MSTP Curriculum and Programming
Associate Professor, Department of Microbiology
Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine
Faculty Publications
Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.
Megakaryocyte phenotyping in response to SARS-CoV-2 variants
Platelets. 2025 Dec ; 36:2532459
Prophage-encoded methyltransferase drives adaptation of community-acquired methicillin-resistant Staphylococcus aureus
The Journal of clinical investigation. 2025 Jul 22;
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum
Pediatrics (1948). 2025 Jul 01; 156:
Heterozygosity for Crohn's disease risk allele of ATG16L1 promotes unique protein interactions and protects against bacterial infection
Immunity. 2025 Jun 10; 58:1456-1468.e5
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
Journal of infectious diseases. 2025 Apr 29;
Sex-dependent gastrointestinal colonization resistance to MRSA is microbiota and Th17 dependent
eLife. 2025 Apr 08; 13:
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults
Vaccines. 2025 Apr 03; 13:
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study
Open forum infectious diseases. 2025 Apr ; 12:ofaf184